Systematic review and meta-analysis of psilocybin therapy reports large reductions in anxiety/major depressive disorder symptoms (SMD −1.44, 95% CI −1.73 to −1.15) and mood disorder symptoms (SMD −1.48); number of studies not stated.
Meta-analysis
Khan et al. Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy